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The smoke chemistry and in vitro toxicity of mainstream smoke (MS) was investigated in American-
blended cigarettes with or without the addition of 2.5%, 5% or 10% eugenol to the tobacco and in Indone-
sian-blended cigarettes with and without the addition of cloves, cloves extracted with hot ethanol, and
extracted cloves replenished with eugenol or clove oil. The addition of eugenol reduced the concentration
of nearly all toxicants measured in MS as well as the in vitro cytotoxicity of the gas/vapor phase. Reduc-
tions were also seen in bacterial mutagenicity of the total particulate matter (TPM) assessed by the Ames
Assay. The addition of extracted cloves led to increases and decreases of toxicant concentrations in MS.
Replenishment with eugenol or clove oil decreased the toxicant concentrations; with most smoke con-
stituent concentrations reduced below the concentration found in tobacco-only cigarettes. Cytotoxicity
of the TPM was not affected by the clove preparations. However, GVP cytotoxicity was reduced
(untreated cloves showing the highest reductions). Mutagenicity of TPM was decreased by the clove
preparations. Mechanisms for the reductions, (up to 40%), are most likely due to dilution effects by
eugenol, changed burning characteristics of the tobacco, and free radical scavenging by eugenol.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction and in vivo toxicity studies. The studies were designed to coverThis publication is part of a series summarizing the in vitro and
in vivo toxicological assessment of kretek cigarettes. Smoke com-
position and biological activity of mainstream smoke (MS) from
marketed and experimental kretek cigarettes were evaluated on
a comparative basis in smoke chemistry analyses, and in vitrothree main topics: (1) characterization of kreteks and comparison
relative to American-blended cigarettes, (2) impact of blend type
and cloves, and (3) impact of ingredients used in kretek cigarettes.
Further in depth information of this assessment is described in the
lead publication (Roemer et al., 2014b).
Kretek cigarettes are tobacco-containing combustible products,
and thus a health hazard for smokers. Such health hazards associ-
ated with smoking tobacco products are well known and docu-
mented (US-DHHS, 2004, 2010). However, additional concern
regarding kretek cigarettes has been raised (Guidotti et al., 1987,
1989; US-DHHS, 2004) as these cigarettes contain a signiﬁcant
amount of cut cloves beside the tobacco in their ﬁller. The clove
content in marketed products accounts for 15–40% of the ﬁller of
these cigarettes (Polzin et al., 2007). Information regarding the
chemical composition and toxicological properties of kretek ciga-
rette smoke is very limited in the scientiﬁc literature. However, it
can be assumed that the combustion and/or distillation products
of cloves will result in smoke that is different in its chemical com-
position from that of cigarettes without cloves.
S42 E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S41–S53In two accompanying publications appearing in the same sup-
plement of this journal (Piadé et al., 2014a,b), kretek cigarettes
were compared to a typical American-blended cigarette. It was
found that, per mass of total particulate matter (TPM), kretek
cigarette smoke contained lower levels of most of the smoke tox-
icants analyzed and showed a lower in vitro and in vivo toxicity in
most endpoints when compared to typical American-blended
cigarettes.
To understand the contributions of the different components in
a typical Indonesian kretek cigarette, i.e., Indonesian tobacco and
cut cloves, to the total in vitro and in vivo toxicity of the cigarette
smoke, a set of experimental cigarettes was designed and manu-
factured to elucidate the impact of the main constituents of the
clove buds, i.e., the oleoresins in the cloves, eugenol as part of
the oleoresins, and the clove matrix without oleoresins. Cigarettes
were designed to differ in only one component from the compara-
tor cigarette.2. Materials and methods
2.1. General
Detailed descriptions regarding the chemical analyses, toxico-
logical assays and statistical procedures can be found in the ﬁrst
of this series of publications (Roemer et al., 2014b).2.2. Cigarettes
The experimental cigarettes with their main characteristics and
code names (Table 1) were as follows:
 American-blended cigarettes with the addition of eugenol at 0
(control, no addition), 2.5, 5, or 10%: US-0, US-2.5, US-5, and
US-10 (US cigarettes),
 a cigarette with a blend of Indonesian tobaccos typical for kre-
tek products without any clove components: IND,
 a cigarette with a blend of tobaccos typical for kretek products
and 370 mg spent cloves per cigarette. Spent cloves are those
that have been depleted in much of the oleoresins (including
eugenol) by hot ethanol extraction. The eugenol concentration
measured in smoke and in ﬁller is reduced to approximately
20% of the original content: IND-SC,
 a cigarette with a blend of tobaccos typical for kretek products
and 370 mg spent cloves where eugenol has been added back to
a concentration of approximately 80% compared to untreated
cut cloves: IND-SC-E,
 a cigarette with tobaccos typical for kretek products with
370 mg spent cloves where the oleoresins have been added
back. The eugenol concentration measured in smoke and in ﬁl-
ler is approximately 90% of what is observed with untreated
cloves: IND-SC-O,
 a kretek with a blend of tobaccos typical for kretek products and
the addition of 370 mg untreated cut cloves per cigarette: IND-
C, which is identical in design to the Kretek-R used in Part 2 and
Part 3 (Piadé et al., 2014a,b), and the Control in Part 6 (Roemer
et al., 2014a) and Part 7 (Schramke et al., 2014) of this
supplement,
 a cigarette with a typical American-blend of tobaccos with the
addition of 370 mg untreated cut cloves per cigarette: US-C,
 an American-blended standard reference cigarette distributed
by the University of Kentucky, USA (Davies and Vaught,
2003): 2R4F. This cigarette is considered to be representative
of the 12-mg TPM segment of commercial US blended cigarettes
(Chen and Moldoveanu, 2003).2.3. Smoke generation
Cigarettes were conditioned according to ISO standard 3402
(ISO, 1999), i.e., at least 48 h at target conditions of 22 C ± 1 C
and a relative humidity of 60% ± 1%. MS was generated under ISO
3308 machine-smoking conditions (International Organization for
Standardization (ISO), 2000). The cigarettes were smoked on a
20-port Borgwaldt rotary smoking machine (RM20H, Hamburg,
Germany). In short, puff volume, puff duration, and puff frequency
for the ISO smoking conditions were 35 ml, 2 s, and 1/min.
Cigarettes were smoked to a ﬁnal butt length of 35 mm.
2.4. Smoke chemistry
In addition to the ISO analytes, TPM, nicotine, carbon monoxide
(CO), and water (ISO, 1991, 2000, 2007), further analytes were
selected based on two source documents: a proposal that speciﬁ-
cally focused on smoke chemistry testing from the US Consumer
Product Safety Commission (US-CPSC, 1993) and a monograph
from the International Agency for Research on Cancer (IARC,
1985). Analytes were quantiﬁed according to established method-
ology as previously described (Roemer et al., 2004).
2.5. In vitro mammalian cell cytotoxicity
Cytotoxicity of TPM and the water soluble constituents of the
gas/vapor phase (GVP) of MS was assessed with the Neutral Red
Uptake (NRU) assay (Borenfreund and Puerner, 1985, 1987) with
mouse embryo BALB/c 3T3 cells as previously described (Roemer
et al., 2009).
2.6. In vitro bacterial mutagenicity
Mutagenicity of TPM was assessed in the plate incorporation
Salmonella Reverse Mutation Assay (Maron and Ames, 1983)
according to the respective OECD guideline 471 (OECD, 1997a) as
previously described (Roemer et al., 2012). Determinations were
performed in the presence and in the absence of a metabolic
activation system.
2.7. In vitro mammalian cell genotoxicity
Genotoxicity of eugenol and TPM was assessed in the Mouse
Lymphoma Assay (MLA) developed by Clive (Clive et al., 1972),
and was performed according to OECD guideline 476 (OECD,
1997b) in the microtiter plate version (Cole et al., 1986) as
described in detail by Schramke et al. (2006).
2.8. Laboratories
The experimental work was carried out in two laboratories:
Cigarettes US-0 to US-10 were assessed at IIT Research Institute
(IITRI), Chicago, USA; cigarettes IND, IND-SC, IND-SC-E, IND-SC-O,
IND-C, and US-C were assessed at Philip Morris Research
Laboratories (PMRL), Cologne, Germany.
3. Results
3.1. Smoke chemistry
Eugenol added as neat substance up to 10% to American-blended
cigarettes compared to otherwise identical control cigarettes with-
out eugenol, resulted in a eugenol-concentration dependent
increased yield of up to +30% TPM per cigarette and up to +40%
tar. The yield of nicotine per cigarette was not affected. The yield
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6% decrease at the highest addition level. Generally, there was a
decreased delivery of smoke toxicants per cigarette. At the highest
level of eugenol addition the decreases, as a mean, amounted to
approximately 20%. However, the yields of formaldehyde and
hydrogen cyanide (HCN) were increased (statistically signiﬁcant
for HCN only), while CO, nitrogen oxides (NOx), and vinyl chloride
stayed constant (Appendix, Table A).
On a per mg TPM basis, distinct and statistically signiﬁcant,
eugenol-concentration dependent decreases for nearly all of the
measured smoke constituents were observed. At the highest addi-
tion level of 10% eugenol, nearly all smoke constituents were sta-
tistically signiﬁcantly decreased, as a mean, by approximately
35%. For formaldehyde and HCN, the decreases were around
15%, while for some constituents, e.g., N-nitrosodimethylamine,
the decreases were higher than 50% (Fig. 1).
On a per mg tar or nicotine basis, general reductions in smoke
toxicants were also observable. The mean decreases at 10% eugenol
addition were 40% and 15%, respectively. On a per mg nicotine
basis, formaldehyde (statistically signiﬁcant) and HCN (statistically
not signiﬁcant) were increased by +15% (Fig. 2).
Spent cloves (SC), SC plus eugenol, SC plus oleoresin, or full
cloves were added at an amount of 370 mg to cigarettes with an
Indonesian tobacco blend, i.e., additions of approximately +30%
to the ﬁller. The additions of these clove preparations resulted in
increased yields of TPM per cigarette by approximately +10%,
+20%, +25%, and +35%, respectively. The tar yields were similarly
increased. The yields of nicotine were not affected. The puff count
increased for all clove preparations by approximately +40%. Several
toxicants, e.g., benzene, phenolics, and polycyclic aromatic hydro-
carbons (PAHs) were increased up to +30% on a per cigarette basis
(Appendix, Table A). On a per mg TPM basis, the addition of SC to
the tobacco led to statistically signiﬁcant increases, e.g., in 1,3-
butadiene, benzene, catechol, pyrene, and PAHs. Statistically signif-
icant decreases were seen for, e.g., nicotine, water, formaldehyde,
acetamide, acrylamide, and tobacco-speciﬁc N-nitrosamines
(TSNAs). When the SC were replenished with eugenol or oleoresin,
or when untreated cut cloves were added to the tobacco, the yield
of nearly all measured smoke toxicants decreased on a per mg TPM
basis. The decreases were such, that some of the increased toxi-
cants, e.g., PAHs, reverted back to the levels found for the tobacco
without any addition, but most of the smoke toxicants decreased
substantially below the levels found for the tobacco only, e.g.,
decreases up to approximately40% for carbonyls, 2-nitropropane,
and TSNAs (Fig. 3).
As the addition of the clove preparations increased TPM and tar
yields in a similar way, a comparison of the deliveries of MS toxi-
cants on a per mg tar basis leads to the same ﬁndings as to those
expressed on a per mg TPM basis. In the same way, the comparison
on a per mg nicotine basis is equivalent to a comparison on a per
cigarette basis, as the nicotine yields per cigarette were virtually
the same for all cigarette types. However, in contrast to the TPM-
based evaluation, a comparison on a per mg nicotine basis showed
either equal deliveries, e.g., aldehydes and NOx, or increased deliv-
eries, e.g., PAHs and phenols. The increases were nearly all statisti-
cally signiﬁcant (Fig. 2).
The TPM yields of the reference cigarette 2R4F and US cigarettes
or the cigarette US-C are too different to allow a meaningful com-
parison of their smoke toxicants deliveries on a per cigarette basis
when assessing the effects of clove preparations on American-
blended cigarettes. However, the comparison of the cigarette
IND-C with Indonesian tobacco with the American-blended ciga-
rette US-C, both with the addition of full cloves, shows roughly
the same TPM and smoke toxicant deliveries per cigarette. Excep-
tions are a few distinct tobacco blend-related differences, as in the
IND-C lower nitrogen containing toxicants such as 2-nitropropane,
S44 E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S41–S53NOx, and TSNAs and higher phenolics, and PAHs in the Indonesian-
blended cigarette (Appendix, Table A). On a per mg TPM basis, the
differences were the same as on a per cigarette basis (Fig. 4). The
comparison of the American-blended reference cigarette 2R4F
without cloves with the cigarette US-C with full cloves on a per
mg TPM basis reveals similar decreases in the yields of MS toxi-
cants as seen for the Indonesian-blended cigarettes due to the
addition of cloves and its components. As in the Indonesian-
blended cigarettes, the deliveries of TSNAs were not decreased
compared to a non-clove cigarette. The comparisons performed
on a per mg tar or nicotine basis lead to the same conclusions for
the American-blended cigarettes as those derived for the Indone-
sian-blended cigarettes.
The transfer rates of eugenol in the ﬁller into the smoke were
approximately 12%, irrespectively if the eugenol was added as pure
substance or was part of the cloves (Table 1).3.2. In vitro mammalian cell cytotoxicity
For all cigarette types, the TPM and the GVP of the MS produced
concentration-dependent decreases in the number of viable cells
typical of the concentration/response relationships known from
literature (Bombick et al., 1998; Roemer et al., 2002). The calcula-
tion of the EC50, as the key measure of effect, could be performed
without any extrapolations.
Eugenol added as a neat substance to American-blended ciga-
rettes had little effect on the cytotoxicity of the TPM. At the highest
addition level of 10% eugenol, there was a statistically non-signif-
icant decrease in cytotoxicity by approximately 10%. The cytotox-
icity of the GVP, however, was decreased by 40%. The dose-
dependent decrease in activity of GVP was statistically signiﬁcant
at the high eugenol addition level under all calculation bases, i.e.,
per mg TPM, per mg tar, per mg nicotine, or per cigarette (Fig. 5,
see Appendix, Table B for cigarette basis).
The addition of 370 mg of SC, SC plus eugenol, SC plus oleoresin,
or full cloves to cigarettes with an Indonesian tobacco blend0
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Fig. 1. Smoke constituent yields per mg TPM of American-blended cigarettes with the ad
eugenol. Remarks: order of results of statistical tests: comparison of cigarette without a
addition; =, statistically not signiﬁcant; ⁄, statistically signiﬁcant.resulted, relative to the cigarette without any clove components,
in a TPM with a cytotoxicity of 94%, 92%, 92%, and 93%, respec-
tively. The corresponding data for the GVP were 90%, 73%, 65%,
and 63%, respectively (Fig. 5). On a per mg tar basis, the percent-
ages were nearly the same. The differences in GVP activity between
the cigarette without addition and those with SC plus eugenol or
oleoresin and those with full cloves were statistically signiﬁcant.
The nicotine delivery per cigarette was not affected by the addition
of the clove components but the TPM delivery was increased, as
observed already in the independent chemical analyses of MS pre-
sented above. Accordingly, on a per mg nicotine basis, the TPM
cytotoxicity was increased by the addition of clove components
and the decreases seen for the GVP were smaller. The percentages
in the same order as given above were 109%, 112%, 124%, and 129%
for TPM and 105%, 88%, 87%, and 88% for GVP, respectively.
Comparing the American-blended cigarette with full cloves
with the American-blended standard reference cigarette 2R4F
without cloves revealed a distinct reduction in the GVP activity
as seen in the Indonesian-blended cigarette, i.e., a reduction of
approximately 45% on a per mg TPM basis. On a per mg nicotine
basis, the mean reduction in the cytotoxic activity of the GVP due
to the addition of full cloves was also 45%. However, one has to
take into account the approximately 20% higher concentration of
nicotine in TPM of the reference cigarette 2R4F compared to the
cigarette with the Indonesian tobacco.
The comparison, on a per mg TPM basis, of the American-
blended cigarette US-C with the cigarette IND-C with Indonesian
tobacco, both with the addition of full cloves and different only
in the blend, shows no statistically signiﬁcant difference in the
cytotoxicity of the TPM and GVP. The differences were less than
10%. (See Appendix, Table B for data on a per cigarette basis.)3.3. In vitro bacterial mutagenicity
For all cigarette types, the administration of their TPM produced
concentration-dependent increases in the number of revertants in2O */*/*
Nicone  */*/*
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dition of eugenol to the ﬁller relative (%) to control cigarettes without the addition of
ddition of eugenol to 2.5% eugenol addition/to 5% eugenol addition/to 10% eugenol
Fig. 2. Smoke constituent yields per mg TPM of cigarettes with Indonesian tobacco with the addition of clove preparations to the ﬁller relative (%) to control cigarettes
without the addition of clove components. Remarks: order of results of statistical tests: comparison of cigarette IND to IND-SC/to IND-SC-E/to IND-SC-O/to IND-C; =,
statistically not signiﬁcant; ⁄, statistically signiﬁcant.
Fig. 3. Smoke constituent yields per mg nicotine of an American-blended cigarettes with the addition of 10% eugenol or a cigarette with Indonesian Tobacco with the addition
of full cloves relative (%) to their respective controls without addition. Remarks: order of results of statistical tests: comparison of cigarette without addition of eugenol to 10%
eugenol addition/comparison of cigarette without cloves to cigarette with cloves; =, statistically not signiﬁcant; ⁄, statistically signiﬁcant.
E. Roemer et al. / Regulatory Toxicology and Pharmacology 70 (2014) S41–S53 S45tester strains TA98, TA100, and TA1537 with S9 metabolic activa-
tion and in TA100 without metabolic activation. Due to the quan-
tiﬁable mutagenic response and the low intra-assay variability, the
results obtained in tester strains TA98 and TA100 with S9 meta-
bolic activation could be utilized for quantitative comparisons of
the different TPM samples. The responses in TA100 without and
in TA102 and TA1537 with S9 metabolic activation were sufﬁcientfor qualitative analysis (semi-responsive). As anticipated (Chepiga
et al., 2000), the other tester strains/activations were not
responsive.
Eugenol added as neat substance to American-blended ciga-
rettes resulted in a decreased mutagenic activity of the TPM for
strains TA98, TA100, TA102, and TA1537 with S9 metabolic activa-
tion, correlating inversely to the increased addition levels of
Fig. 4. Smoke constituent yields per mg TPM of cigarettes with Indonesian tobacco with the addition of full clove to the ﬁller relative (%) to an American-blended cigarette
with the same addition of clove components. Remarks: =, statistically not signiﬁcant; ⁄, statistically signiﬁcant.
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tion at the high 10% eugenol addition dose was statistically signif-
icant (with the exception of TA102) about 50% on a per mg TPM
or tar basis. Based on equal nicotine basis, the reductions were also
about the same, i.e., 40%.
The addition of 370 mg of SC, SC plus eugenol, SC plus oleoresin,
or full cloves to cigarettes with an Indonesian tobacco blend
resulted, in a TPM with reduced mutagenicity, relative to the ciga-
rette without any clove components. For the most sensitive tester
strain, TA98 with S9 metabolic activation, the respective activities
per mg TPM were 72%, 76%, 72%, and 57%. All differences were sta-
tistically signiﬁcant. The second most sensitive tester strain, TA100
with S9 metabolic activation, showed activities of 86%, 68%, 60%,
and 73%, respectively. All differences were statistically signiﬁcant
(Fig. 6). The semi-responsive tester strains indicated decreases or
at least no elevated activity. Activities expressed on a per mg tar
basis resulted in nearly the same relative decreases. On a per mg
nicotine basis, the decreases were less expressed in TA98 and
TA100 with S9 metabolic activation. In the semi-responsive tester
strains, however, a numerical increase could be calculated.
Comparing the American-blended cigarette with full cloves
with the American-blended standard reference cigarette 2R4F
without cloves revealed a distinct, in most cases statistically signif-
icant, reduction in the mutagenic activity by approximately 40%
on a per mg TPM or tar basis considering both the responsive
and the semi-responsive tester strains. This decreased mutagenic
activity was also evident on a per mg nicotine basis, even when
accounting for the higher nicotine delivery in the reference ciga-
rette 2R4F when expressed on a per mg TPM basis.
Comparing, on a per mg TPM basis, the American-blended cig-
arette US-C with the Indonesian-blended cigarette IND-C (both
with the addition of full cloves and different only in the tobacco
blend) showed differences in both positive and negative directions
depending on the tester strain. In TA98 and TA100 with S9 meta-
bolic activation, the American blend was approximately +40%and +20% more mutagenic in vitro than the Indonesian blend (sta-
tistically signiﬁcant for TA98). However, in TA100 without S9 met-
abolic activation and TA1537 with S9 metabolic activation a
decreased activity of approximately 30% and 20%, respectively,
was observed (statistically not signiﬁcant). (See Appendix, Table B
for data on a per cigarette basis.)3.4. In vitro mammalian cell genotoxicity
Eugenol tested as neat substance in the MLA without metabolic
activation showed no cytotoxicity or genotoxicity up to a concen-
tration of 25 lg/ml.
When tested in the presence of the metabolic activation system,
a profound cytotoxic effect was seen at 20 lg/ml. At the same con-
centration, an increase in the mutant frequency by a factor of 2 was
seen compared to the solvent control (Table 2).4. Discussion
4.1. Smoke chemistry
The incorporation of eugenol up to an addition level of +10%,
i.e., 71 mg eugenol/cigarette, to an American-blended cigarette
led to an increase in TPM of up to +30%, i.e., 3.0 mg TPM/cigarette.
Eugenol is found practically exclusively in the particulate phase of
MS (Polzin et al., 2007) and has a high transfer rate into the smoke.
Eugenol in the blend and MS of these cigarettes resulted in a trans-
fer rate of approximately 12%, i.e., up to 4.6 mg eugenol/cigarette
(even when measured several months after the completion of the
study). This ﬁgure is practically the same obtained from the other
experimental cigarettes that show a transfer of approximately 12%
of the eugenol from the cloves or clove components into the MS. As
such, this increase in TPM can be explained completely by a dilu-
tion effect resulting from the transfer of eugenol into the MS. When
Fig. 5. In vitro cytotoxicity per mg TPM of American-blended cigarettes with the addition of eugenol or cigarettes with Indonesian tobacco with the addition of clove
preparations to the ﬁller relative (%) to control cigarettes without the addition of eugenol or clove components. Remarks: (a) and (b), different laboratories; ⁄ = statistically
signiﬁcant.
Fig. 6. In vitro bacterial mutagenicity per mg TPM of an American-blended cigarette with the addition of eugenol or cigarettes with Indonesian tobacco with the addition of
clove preparations to the ﬁller relative (%) to control cigarettes without the addition of eugenol or clove components. Remarks: TAx + S9, Salmonella strain x with metabolic
activation; (a) and (b), different laboratories; ⁄, = statistically signiﬁcant.
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rette is left. Assuming a conversion rate of 1.3% for tobacco into
TPM, 8.3 mg TPM/cigarette from tobacco would be expected.
Together with the amount of eugenol in TPM (4.6 mg/cigarette),
this sums up to an expected 12.9 mg TPM/cigarette. This is consis-
tent with the 12.3 mg TPM/cigarette determined. Analyzing the
yields of smoke toxicants on a per mg TPM basis, the situation is
less clear. Decreases were found down to approximately 60% for
N-nitrosodimethylamine but some toxicants such as HCN were
only reduced by 5%. Tobacco smoke-derived TPM accounts for2/3 of the TPM. Accordingly, some changes in the burning charac-
teristics have to be postulated. Unexpectedly, the yield of nicotine
per cigarette was not affected although up to 10% of the tobacco
was replaced by eugenol. This suggests that the mechanism
requires further investigation.
The addition of approximately +30% SC, i.e., cloves where the
oleoresin had been extracted, resulted in an increased yield of
benzene, phenolics, and PAHs of the same percentage on a per
cigarette basis. Replenishment of the SC either with eugenol or
with the complete oleoresins did not alter this increased yield. This
Table 2
In vitro genotoxicity of pure eugenol in the Mouse Lymphoma Assay.
Metabolic
activation
Eugenol concentration
(lg/ml)
Mutant frequency
(mutants/1E5 survivors)
RTG (%)
No 0 33.2 96.0
0 24.4 104.0
5 19.9 116.8
10 25.6 128.5
15 19.1 90.3
20 25.5 118.5
25 19.1 138.1
Yes 0 29.6 94.3
0 24.4 105.5
5 18.8 88.4
10 28.4 62.1
15 31.7 57.8
20 58.5 18.3
Remarks: RTG = relative total growth.
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cigarettes where only eugenol was included. However, at an addi-
tion level of 5% pure eugenol in the tobacco, the decreases were not
very obvious. However, they were distinctly obvious at an addition
level of 10% eugenol in the tobacco. The eugenol content in the cig-
arettes where the SC were replenished with eugenol or the com-
plete oleoresin or where full cloves were used was less than 4%;
a eugenol concentration where a distinct effect of the eugenol
would not be expected. The TPM yield was signiﬁcantly increased
up to +35% in the order SC, SC plus eugenol, SC plus oleoresins, and
full cloves. This was accompanied by decreased concentrations in
TPM for some analytes to the levels found for tobacco without
any clove components, for others smoke toxicant levels the reduc-
tions were more distinct, e.g., a 30% decrease for the aldehydes
and TSNAs. The absolute increase in TPM due to the addition of
unchanged cloves was 8 mg per cigarette. The eugenol in TPM
accounted for 5 mg per cigarette. Obviously, the decreased concen-
trations of the toxicants in TPM cannot fully be explained by a sim-
ple dilution by the eugenol, which would result in a decrease of
20%. The combustion of organic materials always results in the
production of toxicants (Sallsten et al., 2006). As such, the combus-
tion of cloves should also have generated some aldehydes. In sum-
mary, the decreased toxicant concentrations in MS are the result of
a dilution by eugenol and some changes in the burning character-
istics and/or interactions of combustion products of clove with
tobacco smoke components.
On a per mg TPM basis, the comparison of the American-
blended reference cigarette 2R4F without cloves with the Ameri-
can-blended cigarette with unchanged cloves showed the same
decreases in smoke toxicant concentrations as seen for the ciga-
rettes with Indonesian tobacco. Obviously, the choice of the
tobacco blend is of minor importance when investigating the
effects of tobacco ingredients. This is in accordance with the liter-
ature. Several authors studying the addition of the same ingredi-
ents to control cigarettes made from different blends have
reached the same conclusion (Baker et al., 2004; Renne et al.,
2006; Rustemeier et al., 2002).4.2. In vitro mammalian cell cytotoxicity
For the TPM, cytotoxicity could be found around 200 mg/l for
the reference cigarette 2R4F on a per mg TPM basis. Cytotoxic con-
centrations of eugenol in vitro have been reported to be around
150 mg/l culture medium (Chang et al., 2000; Ho et al., 2006;
Schnitzler et al., 2008) to 400 mg/l (Maralhas et al., 2006; Prashar
et al., 2006). As such, the toxicity of eugenol is similar to that of
TPM on an equal weight basis. Accordingly, a pure dilution effect
due to the eugenol in the TPM is unlikely as a cause for the slightly,approximately 10%, decreased cytotoxicity of the TPM of the cig-
arettes with the addition of eugenol. Another explanation beside
the reduced toxicity due to a reduction of unknown toxic combus-
tion products, might be the antioxidant and radical-scavenging
activity of eugenol (Atsumi et al., 2001; Fujisawa et al., 2000,
2002; Kadoma et al., 2007). Other components of the oleoresins,
especially b-caryophyllene, exhibit the same chemical properties
to a signiﬁcant extent (Chang et al., 2013; Siani et al., 2013).
For the GVP, the decreased yield of smoke toxicants as a func-
tion of the eugenol addition was accompanied by a signiﬁcant
decrease (up to 40% to 50%) of the in vitro cytotoxicity.
However, with the exception of acrolein, the GVP constituents
measured in the smoke contribute only to a minor degree to the
cytotoxicity as measured in the NRU assay (Tewes et al., 2003).
Tewes et al. determined for acrolein a contribution of 42% for the
GVP cytotoxicity of the University of Kentucky standard reference
cigarette 1R4F. In our laboratory, the long-term EC50 value for acro-
lein is 0.0308 lmol/ml or 1.73 lg/ml. The EC50 value for the GVP of
the control cigarette (US-0) turned out to be 0.202 mg TPM/ml and
the acrolein yield 5.41 lg/mg TPM, i.e., 1.09 lg/0.202 mg TPM.
Thus, assuming simply linear relationships and no interactions of
smoke constituents, the contribution of acrolein to the GVP cyto-
toxicity was 63% ((1.09  100)/1.73). Compared to the control cig-
arette, the cigarette with the incorporation of 10% eugenol showed
a 40% lower acrolein yield per mg TPM and a decrease in cytotox-
icity by 37%. Performing the same simpliﬁed calculation as above,
the contribution of acrolein to the cytotoxicity is practically the
same, i.e., 61%. However, one would expect a reduction of cytotox-
icity due to the reduced acrolein by 40  61/100 = 24%. Obviously,
the reduction in acrolein does not explain the effect completely. As
the analysis of eugenol in the GVP fails to provide any detectable
analyte signal by GC/MS (Polzin et al., 2007), it therefore seems
unlikely that pure eugenol with its antioxidant and radical-scav-
enging activity is responsible for this effect. Pyrolysis products of
eugenol are also unlikely to be the cause of the effect as eugenol,
due to its volatility, should be nearly completely transferred with-
out decomposition to MS similar to other compounds with similar
physical–chemical characteristics (Baker and Bishop, 2004). It
remains a possibility that eugenol may change the burning charac-
teristics of the cigarette towards the production of less smoke
toxicants.
The addition of cloves or clove components did not alter the
cytotoxicity of the TPM of the smoke. The addition of spent cloves,
showed a reduction in the cytotoxicity of the GVP. A replenishment
of the spent cloves with eugenol or the complete oleoresins did add
to this effect. Addition of unchanged cloves showed the highest
reduction. There was a tendency for increasing reductions in the
order the cigarette compositions are mentioned above. The reduc-
tions in GVP toxicity correlate with the eugenol content in the
blend. As for the series with the addition of pure eugenol (see
above), a dilution effect and a change in the burning characteristic
with a consequent change in smoke toxicant levels might be a rea-
sonable explanation.
4.3. In vitro bacterial mutagenicity
Eugenol is not mutagenic in the Ames assay as conﬁrmed in
several laboratories (Azizan and Blevins, 1995; Dorange et al.,
1977; Sekizawa and Shibamoto, 1982; Stea et al., 1994; To et al.,
1982). Therefore, increases in the Ames mutagenicity due to the
contribution from unchanged eugenol transferred from the ciga-
rette ﬁller into the smoke TPM are not expected. On the other hand,
considering the large decreases (up to 50%) in mutagenicity due to
the addition of eugenol to the tobacco, pure dilution effects can be
excluded as well, as eugenol may account only for up to one third
of the TPM mass. It might be speculated that a combination of a
Table A
Smoke chemistry.
Analyte Cigarette type
US-0 US-2.5 US-5 US-10 2R4F(a) IND IND-SC IND-SC-E IND-SC-O IND-C US-C 2R4F(b)
FTC parameters
TPM (mg/cig) 9.29 ± 0.13 (4) 10.2 ± 0.30 (4) 11.3 ± 0.54 (4) 12.3 ± 0.15 (4) 11.0 ± 0.3 (4) 24.6 ± 0.3 (4) 27 ± 0.3 (4) 29.9 ± 0.3 (4) 31 ± 0.2 (4) 32.9 ± 0.2 (4) 29.4 ± 0.3 (4) 10.2 ± 0.1 (4)
Tar (mg/cig) 7.87 ± 0.09 (4) 8.84 ± 0.20 (4) 9.94 ± 0.48 (4) 11.0 ± 0.15 (4) 9.12 ± 0.17 (4) 19.5 ± 0.3 (4) 22.1 ± 0.2 (4) 24.9 ± 0.3 (4) 26.4 ± 0.1 (4) 28.3 ± 0.2 (4) 25.1 ± 0.2 (4) 8.31 ± 0.07 (4)
Nicotine (mg/cig) 0.800 ± 0.012 (4) 0.825 ± 0.014 (4) 0.852 ± 0.020 (4) 0.793 ± 0.010 (4) 0.838 ± 0.025 (4) 1.92 ± 0.05 (4) 1.88 ± 0.02 (4) 1.88 ± 0.03 (4) 1.88 ± 0.01 (4) 1.89 ± 0.05 (4) 1.76 ± 0.02 (4) 0.759 ± 0.026 (4)
Water (mg/cig) 0.626 ± 0.032 (4) 0.531 ± 0.092 (4) 0.535 ± 0.095 (4) 0.494 ± 0.030 (4) 1.07 ± 0.18 (4) 3.14 ± 0.07 (4) 3.05 ± 0.15 (4) 3.16 ± 0.14 (4) 2.77 ± 0.07 (4) 2.79 ± 0.14 (4) 2.56 ± 0.1 (4) 1.18 ± 0.02 (4)
Carbon monoxide (mg/
cig)
11.8 ± 0.26 (4) 12.6 ± 1.1 (4) 12.0 ± 0.82 (4) 12.7 ± 0.57 (4) 13.9 ± 0.21 (4) 15.6 ± 0.1 (4) 17.9 ± 0.2 (4) 17.2 ± 0.2 (4) 16.1 ± 0.2 (4) 16.7 ± 0.2 (4) 16.9 ± 0.2 (4) 11.5 ± 0.1 (4)
Puff count (n) 8.6 ± 0.09 (4) 8.5 ± 0.058 (4) 8.5 ± 0.50 (4) 8.1 ± 0.13 (4) 9.1 ± 0.096 (4) 10.4 ± 0.1 (4) 15 ± 0.1 (4) 15 ± 0.1 (4) 14.6 ± 0.1 (4) 14.7 ± 0.1 (4) 14.5 ± 0.2 (4) 8.1 ± 0.04 (4)
Aliphatic dienes
1,3-Butadiene (lg/cig) 27.2 ± 0.8 (4) 28.1 ± 1.7 (4) 26.1 ± 2.2 (4) 26.0 ± 2.4 (4) 28.7 ± 3.2 (4) 58.2 ± 2.4 (5) 74.7 ± 1.1 (5) 70.7 ± 2 (5) 72.1 ± 3 (5) 76.9 ± 1.6 (5) 77.5 ± 1.9 (5) 32.3 ± 1.1 (5)
Isoprene (lg/cig) 327 ± 9 (4) 327 ± 9.3 (4) 311 ± 11 (4) 294 ± 4.5 (4) 343 ± 8.3 (4) 491 ± 17 (5) 430 ± 6 (5) 415 ± 18 (5) 432 ± 8 (5) 470 ± 12 (5) 599 ± 14 (5) 333 ± 4 (5)
Aldehydes
Formaldehyde (lg/cig) 16.1 ± 0.5 (4) 18.7 ± 1.3 (4) 19.2 ± 1.7 (4) 18.7 ± 4.1 (4) 17.3 ± 2.0 (4) 56.7 ± 1.6 (10) 53 ± 1.4 (10) 54.9 ± 1.4 (10) 55.9 ± 2.2 (10) 53.4 ± 1.3 (10) 40.1 ± 1.5 (10) 18 ± 0.6 (10)
Acetaldehyde (lg/cig) 592 ± 14 (4) 598 ± 17 (4) 562 ± 19 (4) 505 ± 80 (4) 628 ± 47 (4) 759 ± 12 (10) 788 ± 8 (10) 760 ± 10 (10) 741 ± 12 (10) 706 ± 11 (10) 749 ± 12 (10) 516 ± 9 (10)
Acrolein (lg/cig) 50.3 ± 2.0 (4) 50.4 ± 0.95 (4) 46.3 ± 3.6 (4) 39.8 ± 6.3 (4) 55.0 ± 6.2 (4) 92.6 ± 1.5 (10) 100 ± 1 (10) 93.5 ± 1.8 (10) 94.8 ± 1.7 (10) 89.7 ± 1.9 (10) 88.2 ± 1.3 (10) 51.3 ± 1.2 (10)
Propionaldehyde (lg/
cig)
45.4 ± 2.1 (4) 44.5 ± 4.1 (4) 41.5 ± 3.7 (4) 37.2 ± 7.3 (4) 48.8 ± 6.4 (4) 67.9 ± 1 (10) 74 ± 0.7 (10) 70.7 ± 1.4 (10) 69.2 ± 0.9 (10) 66.1 ± 1.0 (10) 67.3 ± 0.9 (10) 42.1 ± 1.5 (10)
Crotonaldehyde (lg/cig) – – – – – 29.5 ± 0.4 (10) 29.6 ± 0.4 (10) 26.9 ± 0.5 (10) 26.3 ± 0.7 (10) 24.8 ± 0.6 (10) 21.6 ± 0.6 (10) 10.8 ± 0.5 (10)
Acid derivatives
Acetamide (lg/cig) 3.98 ± 0.32 (4) 3.84 ± 0.61 (4) 3.57 ± 0.44 (4) 3.29 ± 0.32 (4) 5.50 ± 0.54 (4) 12.1 ± 0.4 (5) 10.9 ± 0.2 (5) 11.2 ± 0.2 (5) 10.6 ± 0.1 (5) 11.5 ± 0.3 (5) 9.34 ± 0.18 (5) 4.07 ± 0.11 (5)
Acrylamide (lg/cig) – – – – – 5.38 ± 0.22 (4) 4.23 ± 0.16 (4) 4.24 ± 0.2 (4) 4.2 ± 0.15 (4) 4.49 ± 0.19 (4) 3.79 ± 0.09 (4) 1.7 ± 0.04 (4)
Acrylonitrile (lg/cig) 9.99 ± 0.22 (4) 9.56 ± 0.70 (4) 8.88 ± 0.91 (4) 7.21 ± 0.47 (4) 10.0 ± 0.53 (4) 44.8 ± 1 (5) 53.4 ± 0.6 (5) 49.9 ± 1.3 (5) 50.4 ± 1.2 (5) 53.3 ± 1.1 (5) 54 ± 1.1 (5) 28.6 ± 0.3 (5)
Nitro compounds
2-Nitropropane (ng/cig) 18.9 ± 0.07 (4) 17.3 ± 0.72 (4) 15.0 ± 0.87 (4) 13.6 ± 1.6 (4) 19.4 ± 0.66 (4) 23.2 ± 0.3 (4) 21.9 ± 0.5 (4) 21.1 ± 0.3 (4) 20.6 ± 0.5 (4) 17.9 ± 0.7 (4) 22.4 ± 0.9 (4) 18.3 ± 0.9 (4)
Aromatic amines
o-toluidine (ng/cig) 54.9 ± 0.33 (4) 49.7 ± 1.7 (4) 48.8 ± 0.78 (4) 43.8 ± 2.6 (4) 51.5 ± 0.91 (4) 103 ± 2 115 ± 1 (6) 114 ± 1 (6) 113 ± 1 (6) 118 ± 1 (6) 104 ± 1 (6) 49.1 ± 0.6 (6)
o-anisidine (ng/cig) 3.02 ± 0.08 (4) 2.91 ± 0.14 (4) 2.74 ± 0.087 (4) 2.55 ± 0.047 (4) 2.81 ± 0.20 (4) 3.36 ± 0.06 (6) 3.34 ± 0.06 (6) 3.36 ± 0.14 (6) 3.29 ± 0.04 (6) 3.32 ± 0.06 (6) 3.24 ± 0.03 (6) 2.15 ± 0.09 (6)
2-Naphthylamine (ng/
cig)
7.15 ± 0.14 (4) 6.14 ± 0.15 (4) 5.76 ± 0.22 (4) 5.08 ± 0.28 (4) 6.76 ± 0.18 (4) 10.7 ± 0.3 (6) 11.8 ± 0.2 (6) 11 ± 0.2 (6) 11.2 ± 0.3 (6) 10.8 ± 0.3 (6) 11.8 ± 0.2 (6) 5.71 ± 0.12 (6)
4-Aminobiphenyl (ng/
cig)
1.54 ± 0.020 (4) 1.34 ± 0.016 (4) 1.23 ± 0.035 (4) 0.985 ± 0.042 (4) 1.54 ± 0.055 (4) 1.9 ± 0.1 (5) 2.06 ± 0.1 (5) 1.98 ± 0.09 (5) 1.81 ± 0.07 (5) 1.76 ± 0.06 (5) 1.97 ± 0.05 (5) 0.992 ± 0.044 (5)
Halogen compounds
Vinyl chloride (ng/cig) 24.8 ± 1.6 (4) 26.6 ± 1.9 (4) 24.4 ± 2.4 (4) 26.3 ± 4.8 (4) 27.8 ± 4.1 (4) 60.8 ± 2.2 (5) 61.5 ± 1.8 (5) 59.2 ± 2.0 (5) 63.2 ± 3.1 (5) 71 ± 2.3 (5) 66.3 ± 2 (5) 40.2 ± 0.5 (5)
Inorganic compounds
Nitrogen oxides (mg/
cig)
0.281 ± 0.004 (4) 0.286 ± 0.021 (4) 0.274 ± 0.017 (4) 0.272 ± 0.012 (4) 0.314 ± 0.010 (4) 143 ± 4 (5) 142 ± 3 (5) 139 ± 2 (5) (5)146 ± 4 144 ± 2 (5) 226 ± 4 (5) 270 ± 2 (5)
Hydrogen cyanide (lg/
cig)
125 ± 4.5 (4) 137 ± 4.7 (4) 140 ± 7.9 142 ± 7.6 (4) 148 ± 12 (4) 148 ± 14 (4) 177 ± 17 (4) 153 ± 14 (4) 164 ± 14 (4) 178 ± 9 (4) 159 ± 10 (4) 75.2 ± 2.5 (4)
Monocyclic aromatics
Benzene (lg/cig) 40.2 ± 0.6 (4) 38.1 ± 2.4 (4) 35.7 ± 2.9 (4) 32.4 ± 1.7 (4) 44.0 ± 1.8 (4) 67.7 ± 1.1 (5) 87.3 ± 0.6 (5) 79.5 ± 1.2 (5) 77.6 ± 1.1 (5) 86.3 ± 0.9 (5) 82.1 ± 1.5 (5) 44.6 ± 1.0 (5)
Toluene (lg/cig) 63.7 ± 3.8 (4) 60.2 ± 5.7 (4) 55.2 ± 6.3 (4) 44,9 ± 4.6 (4) 69.2 ± 4.6 (4) 113 ± 2 (5) 142 ± 1 (5) 128 ± 1 (5) 119 ± 2 (5) 138 ± 2 (5) 134 ± 3 (5) 84 ± 0.5 (5)
Styrene (lg/cig) 3.48 ± 0.21 (4) 3.30 ± 0.32 (4) 3.11 ± 0.63 (4) 2,32 ± 0.50 (4) 3.62 ± 0.47 (4) 14.1 ± 0.4 (5) 15.7 ± 0.2 (5) 14.1 ± 0.2 (5) 13.1 ± 0.2 (5) 14.2 ± 0.2 (5) 13.5 ± 0.6 (5) 6.41 ± 0.17 (5)
Tobacco speciﬁc N-nitrosamines
NNN (ng/cig) 146 ± 2.5 (4) 138 ± 6.2 (4) 126 ± 3.1 (4) 109 ± 5.2 (4) 142 ± 6.7 (4) 48.8 ± 1.9 (10) 45.9 ± 1.7 (10) 43 ± 1.6 (10) 39.2 ± 1.1 (10) 41.7 ± 2.1 (10) 73 ± 3.1 (10) 122 ± 4 (10)
NNK (ng/cig) 96.4 ± 1.3 (4) 99.4 ± 2.7 (4) 87.3 ± 2.0 (4) 88.3 ± 5.4 (4) 144 ± 6.9 (4) 23.7 ± 0.7 (10) 20.1 ± 0.8 (10) 23.5 ± 1.2 (10) 19.7 ± 1.1 (10) 20.8 ± 0.8 (10) 25.9 ± 1.2 (10) 109 ± 3 (10)
Volatile N-nitrosamines
NDMA (ng/cig) 3.00 ± 0.23 (4) 3.03 ± 0.52 (4) 2.32 ± 0.33 (4) 1.80 ± 0.33 (4) 2.97 ± 0.72 (4) <10.0 (3) <10.0 (3) <10.0 (3) <10.0 (3) <10.0 (3) <10.0 (3) <5.00 (3)
NMEA (ng/cig) <5.0 (4) <5.0 (4) <5.0 (4) <5.0 (4) <5.0 (4) <20.0 (3) <20.0 (3) <20.0 (3) <20.0 (3) <20.0 (3) <20.0 (3) <10.0 (3)
NDEA (ng/cig) <3.6 (4) <3.6 (4) <3.6 (4) <3.6 (4) <3.6 (4) <14.0 (3) <14.0 (3) <14.0 (3) <14.0 (3) <14.0 (3) <14.0 (3) <7.00 (3)
NPRA (ng/cig) <1.5 (4) <1.5 (4) <1.5 (4) <1.5 (4) <15 (4) <22.0 (3) <22.0 (3) <22.0 (3) <22.0 (3) <22.0 (3) <22.0 (3) <11.0 (3)
NBUA (ng/cig) <5.7 (4) <5.7 (4) <5.7 (4) <5.7 (4) <5.7 (4) <18.0 (3) <18.0 (3) <18.0 (3) <18.0 (3) <18.0 (3) <18.0 (3) <9.00 (3)
NPY (ng/cig) 8.62 ± 0.43 (4) 9.24 ± 0.82 (4) 8.69 ± 1.3 (4) 7.26 ± 0.29 (4) 7.08 ± 0.75 (4) <14.0 (3) <14.0 (3) <14.0 (3) <14.0 (3) <14.0 (3) <14.0 (3) <7.00 (3)
NPI (ng/cig) <4.0 (4) <4.0 (4) <4.0 (4) <4.0 (4) <4.0 (4) <16.0 (3) <16.0 (3) <16.0 (3) <16.0 (3) <16.0 (3) <16.0 (3) <8.00 (3)
(continued on next page)
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Table A (continued)
Analyte Cigarette type
US-0 US-2.5 US-5 US-10 2R4F(a) IND IND-SC IND-SC-E IND-SC-O IND-C US-C 2R4F(b)
Phenols
Phenol (lg/cig) 17.5 ± 0.9 (4) 17.8 ± 1.6 (4) 16.7 ± 0,88 (4) 13.8 ± 1.0 (4) 11.9 ± 1.1 (4) 37.6 ± 0.5 (5) 38.5 ± 0.5 (5) 41.8 ± 0.9 (5) 42.6 ± 0.9 (5) 46.9 ± 0.8 (5) 33.7 ± 0.9 (5) 6.18 ± 0.15 (5)
Catechol (lg/cig) 49.8 ± 1.0 (4) 48.9 ± 2.4 (4) 44.0 ± 1.6 (4) 38.2 ± 0.62 (4) 48.0 ± 1.2 (4) 97.8 ± 0.5 (5) 126 ± 2 (5) 123 ± 1 (5) 114 ± 1 (5) 122 ± 2 (5) 102 ± 2 (5) 36 ± 0.3 (5)
Hydroquinone (lg/cig) – – – – – 62.2 ± 1.1 (5) 73.6 ± 1.1 (5) 72.6 ± 0.4 (5) 67.6 ± 1 (5) 71.4 ± 0.9 (5) 65.8 ± 1.5 (5) 26.6 ± 0.2 (5)
Eugenol (mg/cig) <0.0003 (4) 1.28 ± 0.01 (4) 2.51 ± 0.024 (4) 4.61 ± 0.068 (4) <0.0003 (4) 0.01 ± 0.003 (5) 1.02 ± 0.02 (5) 4.08 ± 0.03 (5) 4.64 ± 0.13 (5) 5.25 ± 0.06 (5) 4.45 ± 0.11 (5) 0.001 ± 0.000 (5)
Polycyclic aromatic hydrocarbons
Pyrene (ng/cig) – – – – – 102 ± 2 (5) 133 ± 2 (5) 129 ± 1 (5) 138 ± 2 (4) 136 ± 2 (5) 118 ± 1 (5) 39.4 ± 0.5 (5)
Benz[a]anthracene (ng/
cig)
10.2 ± 0.38 (4) 10.3 ± 0.58 (4) 9.57 ± 0.90 (4) 8.44 ± 0.95 (4) 11.5 ± 0.37 (4) 31.7 ± 0.6 (5) 41.9 ± 0.5 (5) 40.7 ± 0.4 (5) 41.9 ± 0.6 (4) 42.6 ± 0.7 (5) 38.4 ± 0.5 (5) 12.5 ± 0.2 (5)
Benzo[b]ﬂuoranthene
(ng/cig)
5.56 ± 0.23 (4) 6.06 ± 0.39 (4) 5.36 ± 0.51 (4) 4.44 ± 0.39 (4) 5.63 ± 0.56 (4) 12.5 ± 0.3 (5) 16.8 ± 0.2 (5) 16.9 ± 0.2 (5) 16.6 ± 0.3 (4) 16.6 ± 0.3 (5) 15 ± 0.2 (5) 5.04 ± 0.09 (5)
Benzo[j]ﬂuoranthene
(ng/cig)
2.72 ± 0.06 (4) 2.89 ± 0.32 (4) 2.60 ± 0.23 (4) 1.95 ± 0.26 (4) 3.09 ± 0.28 (4) 8.08 ± 0.18 (5) 10.6 ± 0.2 (5) 10.8 ± 0.1 (5) 11 ± 0.2 (4) 11.1 ± 0.1 (5) 9.89 ± 0.19 (5) 3.09 ± 0.06 (5)
Benzo[k]ﬂuoranthene
(ng/cig)
1.89 ± 0.047 (4) 2.26 ± 0.18 (4) 1.80 ± 0.23 (4) 1.58 ± 0.13 (4) 1.98 ± 0.16 (4) 5.36 ± 0.14 (5) 7 ± 0.13 (5) 6.9 ± 0.08 (5) 7.14 ± 0.17 (4) 7.18 ± 0.25 (5) 6.29 ± 0.15 (5) 1.97 ± 0.03 (5)
Benzo[a]pyrene (ng/cig) 6.51 ± 0.31 (4) 7.13 ± 0.38 (4) 6.34 ± 0.61 (4) 5.37 ± 0.48 (4) 7.04 ± 0.65 (4) 18.2 ± 0.5 (5) 24.3 ± 0.4 (5) 24.3 ± 0.2 (5) 25.2 ± 0.3 (4) 24.9 ± 0.4 (5) 22.1 ± 0.4 (5) 7.19 ± 0.13 (5)
Dibenz[a,h]anthracene
(ng/cig)
0.24 ± 0.012 (4) 0.21 ± 0.018 (4) 0.21 ± 0.001 (4) 0.21 ± 0.006 (4) 0.34 ± 0.043 (4) <2.43 (5) <2.43 (5) <2.43 (5) <2.43 (4) <2.43 (5) <2.43 (5) <0.970 (5)
Dibenzo[a,e]pyrene (ng/
cig)
<0.61 (4) <0.61 (4) <0.61 (4) <0.61 (4) <0.61 (4) 0.592 ± 0.010 (5) – – – – – 0.244 ± 0.002
Dibenzo[a,h]pyren (ng/
cig)
<1.9 (4) <1.9 (4) <1.9 (4) <1.9 (4) <1.9 (4) <0.575 (5) 0.674 ± 0.020 (5) 0.659 ± 0.009 (5) 0.764 ± 0.032 (4) 0.845 ± 0.025 (5) 0.693 ± 0.027 (5) <0.230 (5)
Dibenzo[a,i]pyrene (ng/
cig)
<0.92 (4) <0,92 (4) <0.92 (4) <0,92 (4) <0.92 (4) <0.550 (5) <0.550 (5) <0.550 (5) <0.550 (4) <0.550 (5) <0.550 (5) <0.220 (5)
Dibenzo[a,I]pyrene (ng/
cig)
<0.29 (4) <0.29 (4) <0.29 (4) <0.29 (4) <0.29 (4) <0.475 (5) <0.475 (5) <0.475 (5) <0.475 (4) <0.475 (5) <0.475 (5) <0.190 (5)
Indeno[1,2,3-cd]pyrene
(ng/cig)
2.46 ± 0.047 (4) 2.46 ± 0.20 (4) 2.37 ± 0.15 (4) 2.27 ± 0.18 (4) 3.32 ± 0.22 (4) 8.15 ± 0.19 (5) 10.5 ± 0.2 (5) 10.8 ± 0.1 (5) 10.6 ± 0.3 (4) 10.5 ± 0.2 (5) 9.08 ± 0.18 (5) 3.12 ± 0.04 (5)
5-methylchrysene (ng/
cig)
<4.8 (4) <4.8 (4) <4.8 (4) <4.8 (4) <4.8 (4) <1.00 (5) <1.00 (5) <1.00 (5) <1.00 (4) <1.00 (5) <1.00 (5) <0.400 (5)
Metals
Arsenic (ng/cig) – – – – – 7.31 ± 0.2 (4) 5.36 ± 0.19 (4) 5.23 ± 0.13 (4) 5.38 ± 0.17 (4) 5.3 ± 0.12 (4) 7.19 ± 0.09 (4) 2.85 ± 0.02 (4)
Cadmium (ng/cig) – – – – – 110 ± 2 (4) 102 ± 2 (4) 101 ± 1 (4) 98.1 ± 3 (4) 89.5 ± 2.3 (4) 62.7 ± 1.6 (4) 42.6 ± 0.3 (4)
Chromium (ng/cig) – – – – – <3.61 (4) 4.5 ± 0.14 (4) 6.25 ± 0.5 (4) <4.57 (4) <4.92 (4) <4.27 (4) <1.60 (4)
Nickel (ng/cig) – – – – – <4.73 (4) <5.25 (4) <5.60 (4) <6.00 (4) <6.46 (4) <5.60 (4) <2.10 (4)
Lead (ng/cig) – – – – – 29.8 ± 0.8 (4) 19.9 ± 0.6 (4) 20.4 ± 0.4 (4) 22 ± 0.4 (4) 19.3 ± 0.4 (4) 11.7 ± 0.2 (4) 10.6 ± 0.1 (4)
Remarks: Data represent means and standard errors, numbers in brackets give number of determinations, 2R4F(a) = reference cigarette measured parallel with US cigarettes, 2R4F(b) = reference cigarette measured parallel with
IND cigarettes.
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and radical-scavenging activity of eugenol is responsible for this
effect. Actually, eugenol as a pure substance has been reported to
inhibit TPM induced Ames-mutagenicity. However, the doses
necessary for this reduction suggest a minor contribution to the
reductions seen in our studies (Sukumaran and Kuttan, 1995).
The addition of spent cloves showed a reduction in the mutage-
nicity of the TPM. A replenishment of the spent cloves with euge-
nol or the complete oleoresins did add to this effect. Addition of full
cloves, depending on the tester strain, further increased the effect
or did not lead to a further reduction compared to spent cloves. The
reductions in mutagenicity correlate fairly well with the eugenol
content in the blend. As in case of the cigarettes with the addition
of pure eugenol, a combination of a dilution, a reduced formation
of toxicants by combustion and the antioxidant and radical-scav-
enging activity of eugenol might be responsible for this effect.
4.4. In vitro mammalian cell genotoxicity
Eugenol has been tested in one study as positive in theMLAwith
metabolic activation (Sofuni et al., 1996).Withoutmetabolic activa-
tion there was barely a noticeable effect, although the authors con-
cluded that there was an effect under both conditions. This activity
could be conﬁrmed in the present study with metabolic activation
at a rather high cytotoxic concentration (relative total growth rate
of 20% relative to the control). Generally, this assay system is known
for a rather high rate of false positive responses, especially at cyto-
toxic concentrations (Caldwell, 1993; Lorge et al., 2007; Parry et al.,
2010; Reeve et al., 2012). In other in vitro and in vivo genotoxicity
assays, eugenol shows mixed results, although most of them are
negative (EFSA, 2009). Moreover, eugenol has not been found to
be carcinogenic at high doses in mice and rats after oral administra-
tion. Metabolism studies inman show that 95% of the oral uptake of
eugenol is excreted as otherwise unchanged glucuronide and sul-
fate conjugates in urine (Fischer et al., 1990; Minet et al., 2012). It
has been argued that, although eugenol is positive in some genotox-
icity tests, it is not carcinogenic because it only causes one type of
mutation due to a single DNA adduct (however, for cancer develop-
ment, normally several mutations are required). This one adduct
may stimulate repair mechanisms that overcome the genotoxic
action. This could explain the equivocal results in genotoxicity test-
ing and the negative ﬁnding in the carcinogenicity studies
(Tisserand and Young, 2014).5. Conclusion
Based on the results of the chemical analyses of the smoke and
the in vitro cytotoxicity and mutagenicity assays, neither the use of
Indonesian tobacco nor the addition of ground cloves to cigarette
tobacco suggest a higher hazard potential when compared to
American-blended cigarettes without cloves.
Changes in cytotoxicity and mutagenicity due to the addition of
cloves seem to be a result of a combination of effects: a dilution
effect by the unchanged transfer of eugenol into the smoke, a
change in the burning characteristics with subsequent changes in
smoke chemistry, interactions of combustion products of clove
with tobacco smoke components and, for the particle phase only,
the antioxidant and radical-scavenging activity of eugenol. The
relative contributions of these mechanisms remains unclear and
requires further more reﬁned and targeted investigations.Conﬂict of interest statement
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